Metabotropic Glutamate Receptor 5 Market size was valued at USD 1.2 Billion in 2024 and is forecasted to grow at a CAGR of 9.2% from 2026 to 2033, reaching USD 2.5 Billion by 2033.
The global Metabotropic Glutamate Receptor 5 (mGluR5) market size was valued at approximately USD 1.5 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 8.2% from 2023 to 2030. The increasing prevalence of neurological disorders, such as Alzheimer’s disease, Parkinson’s disease, and schizophrenia, is a key driver for the markets growth. Additionally, growing investments in research and development, particularly for developing novel therapies targeting mGluR5, are expected to fuel market expansion. North America dominated the market in 2022, accounting for over 40% of the total market share, due to the robust healthcare infrastructure, higher adoption of advanced therapeutics, and substantial research funding. The region is expected to continue leading the market during the forecast period, driven by ongoing clinical trials and innovations in pharmaceutical treatments targeting mGluR5.
In terms of regional market share, Europe held the second largest share in 2022, contributing around 30% to the global market. The rising incidence of neurological diseases and the presence of key research institutions and pharmaceutical companies in the region are contributing factors. The Asia Pacific market is anticipated to witness the highest growth rate during the forecast period, with a CAGR of 9.5%, attributed to increasing healthcare investments, a large patient population, and growing awareness of neurological conditions. The Latin American and Middle East & Africa markets are also expected to witness gradual growth, with healthcare developments and improved access to advanced treatments contributing to the expansion of the mGluR5 market in these regions.
Get | Download Sample Copy with TOC, Graphs & List of Figures @ http://verifiedmarketreports.com/download-sample/?rid=862880&utm_source=Pulse_G_May&utm_medium=235
Addex Therapeutics Ltd
Aevi Genomic Medicine Inc Bristol-Myers Squibb Company
Eisai Co Ltd
Eli Lilly and Company
Heptares Therapeutics Ltd
Johnson & Johnson
Merz Pharma GmbH & Co KgaA
Novartis AG
Richter Gedeon Nyrt
Sumitomo Dainippon Pharma Co Ltd
Toray Industries Inc
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=862880&utm_source=Pulse_G_May&utm_medium=235
Growing demand for below applications around the world has had a direct impact on the growth of the Global Metabotropic Glutamate Receptor 5 Market
Cognitive Disorders
Neurodegenerative Diseases
Psychiatric Disorders
Epilepsy
Pharmaceutical Companies
Research Institutions
Hospitals and Clinics
Contract Research Organizations
Agonists
Antagonists
Allosteric Modulators
Oral
Intravenous
Topical
Preclinical Studies
Clinical Trials
Basic Research
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ https://www.verifiedmarketreports.com/product/metabotropic-glutamate-receptor-5-market/
1. Introduction of the Global Metabotropic Glutamate Receptor 5 Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Metabotropic Glutamate Receptor 5 Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Metabotropic Glutamate Receptor 5 Market, By Type
6. Global Metabotropic Glutamate Receptor 5 Market, By Application
7. Global Metabotropic Glutamate Receptor 5 Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Global Metabotropic Glutamate Receptor 5 Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/